Molecular Pathways: Targeting ATR in Cancer Therapy.
Ontology highlight
ABSTRACT: The human ATR gene encodes a kinase that is activated by DNA damage and replication stress as a central transducer of a checkpoint signaling pathway. Once activated, ATR phosphorylates multiple substrates, including the kinase Chk1, to regulate cell-cycle progression, replication fork stability, and DNA repair. These events promote cell survival during replication stress and in cells with DNA damage. Accordingly, there has been the tantalizing possibility that ATR inhibitors would be therapeutically useful, especially if they were more effective in tumor versus normal cells. Indeed, multiple studies have demonstrated that alterations that promote tumorigenesis, such as defects in the ATM-p53 pathway, constitutive oncogene activation, and acquisition of the alternative lengthening of telome
SUBMITTER: Karnitz LM
PROVIDER: S-EPMC4631635 | biostudies-literature | 2015 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA